Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 4, 1998, Pages 421-423

  Núñez, Ma Luz ^a   Martínez Toldos, Ma Carmen ^b   Bru, Mariano ^a   Simarro, Encarna ^a   Segovia, Manuel ^b   Ruiz, Joaquín ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CEFOTAXIME; IMIPENEM; MEROPENEM; SULTAMICILLIN; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ACINETOBACTER; ADULT; ARTICLE; BACTERIAL MENINGITIS; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN VENTRICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; FATALITY; FEMALE; HUMAN; HYDROCEPHALUS; MINIMUM INHIBITORY CONCENTRATION; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 0031793795     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850160774     Document Type: Article

References (13)

1. Bergogne-Bérézin E. The increasing significance of outbreaks of Acinetobacter spp.; the need for control and new agents. J Hosp Infect 1995; 30 Suppl: 441-52.
2. Seifert H, Richter W, Pulverer G. Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobaeter baumannii. Eur J Clin Microbiol Infect Dis 1995; 14: 130-4.
3. Seifert H, Schulze A, Baginski R, Pulverer G. Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol 1994; 32: 1816-9.
4. Siegman-Igra Y, Bar-Yosef S, Gorea A, Avram J. Nosocomial Acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin Infect Dis 1993; 17: 843-9.
5. Sanchez JF, Sanz-Hospital J, Guerrero A, Martinez-Beltrán J, Quereda C. Curación con imipenem-cilastatino de una meningitis por Acinetobacter calcoaceticus. Enferm Infece Microbiol Clin 1991; 9: 512-3.
6. Yogev R. Cerebrospinal fluid shunt infections: a personal view. Ped Infect Dis 1985; 4: 113-8.
7. Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 1993; 167: 448-51.
8. Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994; 32: 2677-81.
9. Paton R, Miles RS, Hood J, Amyes SGB. ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993; 2: 81-8.
10. Sato K, Nakae T. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J Antimicrob Chemother 1991; 28: 35-45.
11. Gerhlein M, Leying H, Cullmann W, Wendt S, Opferkuch W. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy 1991; 37: 405-12.
12. Masuda N, Ohya S. Cross resistance to meropenem, cephems and quinolones in P. aeruginosa. Antimicrob Agents Chemother 1992; 36: 1847-51.
13. Villar HE, Laurino G, Arena MF, Hoffman M. Selección de mutantes resistentes y actividad bacteriostática y bactericida de meropenem y imipenem frente a Acinetobacter spp. Enferm Infec Microbiol Clin 1997; 15: 140-3.